HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo

Nature Medicine
W C GohM Emerman

Abstract

The human immunodeficiency virus type 1 (HIV-1) encodes a protein, called Vpr, that prevents proliferation of infected cells by arresting them in G2 of the cell cycle. This Vpr-mediated cell-cycle arrest is also conserved among highly divergent simian immunodeficiency viruses, suggesting an important role in the virus life cycle. However, it has been unclear how this could be a selective advantage for the virus. Here we provide evidence that expression of the viral genome is optimal in the G2 phase of the cell cycle, and that Vpr increases virus production by delaying cells at the point of the cell cycle where the long terminal repeat (LTR) is most active. Although Vpr is selected against when virus is adapted to tissue culture, we show that selection for Vpr function in vivo occurs in both humans and chimpanzees infected with HIV-1. These results suggest a novel mechanism for maximizing virus production in the face of rapid killing of infected target cells.

References

Apr 1, 1995·Journal of Virology·J S GibbsR C Desrosiers
Nov 1, 1994·AIDS Research and Human Retroviruses·G Myers
Dec 24, 1993·Science·S van den Heuvel, E Harlow
Feb 1, 1993·Current Opinion in Genetics & Development·E Moran
Apr 1, 1996·Journal of Virology·V PlanellesI S Chen
Sep 1, 1996·Current Biology : CB·M Emerman
Oct 17, 1996·Nature·P M SharpB H Hahn
Apr 4, 1997·The Journal of Biological Chemistry·T UchiumiD K Ferris

❮ Previous
Next ❯

Citations

Jul 16, 2008·Apoptosis : an International Journal on Programmed Cell Death·Devon J ShedlockDavid B Weiner
Aug 6, 2009·Apoptosis : an International Journal on Programmed Cell Death·Fang HeTong Wang
Apr 27, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Daiki TaneichiYukihito Ishizaka
Sep 16, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Christopher PowerMaria Polyak
Sep 19, 2003·Current Infectious Disease Reports·Jenny L. Anderson, Thomas J. Hope
Jan 31, 2004·Biochemical and Biophysical Research Communications·Michelle L JanketVelpandi Ayyavoo
May 6, 2003·Biochemical and Biophysical Research Communications·Karuppiah MuthumaniDavid B Weiner
Feb 5, 1999·Biochemical Pharmacology·Y Goldberg
Mar 5, 2003·Journal of Molecular Biology·N MorelletB P Roques
Jul 7, 2000·Mathematical Biosciences·S Holtea, M Emerman
Mar 19, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tricia H HoganBrian Wigdahl
Nov 20, 1998·Current Opinion in Biotechnology·L Naldini
Dec 15, 2000·Trends in Microbiology·M O Hottiger, G J Nabel
Aug 28, 2003·Microbes and Infection·Yuntao Wu, Jon W Marsh
Nov 13, 2010·Proceedings of the National Academy of Sciences of the United States of America·Taisuke IzumiAkifumi Takaori-Kondo
Nov 1, 2007·Journal of Applied Animal Welfare Science : JAAWS·Andrew Knight
Jan 5, 1999·The Journal of Experimental Medicine·T KinoG P Chrousos
Nov 17, 2004·The Journal of Experimental Medicine·Nicola A JonesPersephone Borrow
Oct 25, 2002·DNA and Cell Biology·Michael P ShermanWarner C Greene
Nov 22, 2002·DNA and Cell Biology·Guocheng HeDavid M Margolis
Feb 8, 2003·DNA and Cell Biology·Ricardo Quinonez, Richard E Sutton
May 15, 2004·DNA and Cell Biology·Tomoshige Kino, George N Pavlakis
May 15, 2004·DNA and Cell Biology·Parithosh K TungaturthiAlagarsamy Srinivasan
May 15, 2004·DNA and Cell Biology·Michael Bukrinsky, Yuqi Zhao
May 15, 2004·DNA and Cell Biology·Karuppiah MuthumaniDavid B Weiner
May 15, 2004·DNA and Cell Biology·Shohreh AminiBassel E Sawaya
Feb 24, 2005·AIDS Research and Human Retroviruses·Rupinderjeet KaurDavid Margolis
May 9, 2008·DNA and Cell Biology·Jiangfang WangTerri H Finkel
Feb 10, 2004·Molecular Biology of the Cell·Fred ChangJeremy Luban
Jan 26, 2012·Current Opinion in HIV and AIDS·Hamayun J SharifiCarlos M C de Noronha
Aug 21, 2001·Genes & Development·S PyronnetN Sonenberg
Aug 17, 1999·Microbiology and Immunology·T YamaguchiA Koito
Jul 8, 2011·Journal of Virology·Nozomi SakakibaraAlison A McBride

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.